CB 300919 is a quinazoline-based antitumor agent exhibiting high activity against CH1 human ovarian tumor xenografts, with continuous exposure (96 h) resulting in a growth inhibition (IC50: 2 nM).
Molecular Weight:
584.11
CAS Number:
[289715-28-2]
Formula:
C32H34ClN7O2
Target:
Others|||NAMPT
T14879
* VAT and and shipping costs not included. Errors and price changes excepted